The Democratic Republic of Congo has acquired over 16,000 doses of the Ervebo vaccine in response to the country’s rapid Ebola outbreak, according to the health minister. These 16,250 doses arrived at N’djili International Airport in Kinshasa late Friday. This shipment is part of a larger batch of 70,000 doses anticipated from the World Health Organization and partners, with more scheduled to arrive next week.
This Ebola crisis stems from the Bundibugyo virus, a strain lacking approved treatments or vaccines. Its symptoms can mimic other illnesses, such as malaria, making it challenging to detect. Although the Ervebo vaccine is licensed for Ebola treatment in previous outbreaks, it might offer some protection against this virus strain per WHO insights.
The outbreak has seen 2,557 fatalities from 5,375 confirmed cases in six provinces. It is spreading at a pace that might exceed the 2014-2016 West Africa outbreak, which resulted in over 11,000 deaths. Data from the Africa Centre for Disease Control indicates transmission rates have not reached their peak and could potentially triple.
Efforts to manage the epidemic face obstacles due to the ongoing conflict between government forces and rebel factions, which dominate significant cities in the affected areas. Additionally, attacks targeting medical staff and facilities, a transient labor force, displaced individuals from conflict zones, and inadequate infrastructure further challenge containment measures.